Literature DB >> 30046081

Alzheimer's disease is getting easier to spot.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Alzheimer's disease; Brain; Imaging; Neurodegeneration

Mesh：

Substances：

Year:  2018        PMID： 30046081     DOI： 10.1038/d41586-018-05721-w

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Amyloid biomarkers in Alzheimer's disease.

Authors:  Kaj Blennow; Niklas Mattsson; Michael Schöll; Oskar Hansson; Henrik Zetterberg
Journal:  Trends Pharmacol Sci       Date:  2015-04-01       Impact factor: 14.819

2.  High performance plasma amyloid-β biomarkers for Alzheimer's disease.

Authors:  Akinori Nakamura; Naoki Kaneko; Victor L Villemagne; Takashi Kato; James Doecke; Vincent Doré; Chris Fowler; Qiao-Xin Li; Ralph Martins; Christopher Rowe; Taisuke Tomita; Katsumi Matsuzaki; Kenji Ishii; Kazunari Ishii; Yutaka Arahata; Shinichi Iwamoto; Kengo Ito; Koichi Tanaka; Colin L Masters; Katsuhiko Yanagisawa
Journal:  Nature       Date:  2018-01-31       Impact factor: 49.962

3.  Florbetapir F18 PET Amyloid Neuroimaging and Characteristics in Patients With Mild and Moderate Alzheimer Dementia.

Authors:  Elisabeth K Degenhardt; Michael M Witte; Michael G Case; Peng Yu; David B Henley; Helen M Hochstetler; Deborah N D'Souza; Paula T Trzepacz
Journal:  Psychosomatics       Date:  2015-12-03       Impact factor: 2.386

4.  Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.

Authors:  Ingrid S van Maurik; Marissa D Zwan; Betty M Tijms; Femke H Bouwman; Charlotte E Teunissen; Philip Scheltens; Mike P Wattjes; Frederik Barkhof; Johannes Berkhof; Wiesje M van der Flier
Journal:  JAMA Neurol       Date:  2017-12-01       Impact factor: 18.302

5.  Imaging synaptic density in the living human brain.

Authors:  Sjoerd J Finnema; Nabeel B Nabulsi; Tore Eid; Kamil Detyniecki; Shu-Fei Lin; Ming-Kai Chen; Roni Dhaher; David Matuskey; Evan Baum; Daniel Holden; Dennis D Spencer; Joël Mercier; Jonas Hannestad; Yiyun Huang; Richard E Carson
Journal:  Sci Transl Med       Date:  2016-07-20       Impact factor: 17.956

6.  A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.

Authors:  Eric A Tanifum; Ketan Ghaghada; Craig Vollert; Elizabeth Head; Jason L Eriksen; Ananth Annapragada
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 7.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566
  7 in total
  8 in total

1.  Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.

Authors:  Xiao-Ge Liu; Lun Zhang; Shuai Lu; Dong-Qun Liu; Ling-Xiao Zhang; Xiao-Lin Yu; Rui-Tian Liu
Journal:  Int J Nanomedicine       Date:  2020-07-10

Review 2.  Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran.

Authors:  Klaus Grossmann
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

3.  Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease.

Authors:  Kunie Ando; Christophe Erneux; Mégane Homa; Sarah Houben; Marie-Ange de Fisenne; Jean-Pierre Brion; Karelle Leroy
Journal:  Front Neurosci       Date:  2021-02-25       Impact factor: 4.677

Review 4.  miRNAs as Therapeutic Tools in Alzheimer's Disease.

Authors:  Chang Youn Lee; In Soo Ryu; Jin-Hyeob Ryu; Hyun-Jeong Cho
Journal:  Int J Mol Sci       Date:  2021-12-01       Impact factor: 5.923

Review 5.  Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  Biomedicines       Date:  2022-08-04

6.  Anticoagulants for Treatment of Alzheimer's Disease.

Authors:  Klaus Grossmann
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  scREAD: A Single-Cell RNA-Seq Database for Alzheimer's Disease.

Authors:  Jing Jiang; Cankun Wang; Ren Qi; Hongjun Fu; Qin Ma
Journal:  iScience       Date:  2020-11-05

8.  Brain network analysis reveals that amyloidopathy affects comorbid cognitive dysfunction in older adults with depression.

Authors:  Suji Lee; Daegyeom Kim; HyunChul Youn; Won Seok William Hyung; Sangil Suh; Marcus Kaiser; Cheol E Han; Hyun-Ghang Jeong
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.